Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Feb;125(2):183-9.
doi: 10.1016/j.amjmed.2011.08.014.

Concurrent use of warfarin and antibiotics and the risk of bleeding in older adults

Jacques Baillargeon  1 , Holly M Holmes, Yu-Li Lin, Mukaila A Raji, Gulshan Sharma, Yong-Fang Kuo
Affiliations

Concurrent use of warfarin and antibiotics and the risk of bleeding in older adults

Jacques Baillargeon et al. Am J Med. 2012 Feb.

Abstract

Background: Antibiotic medications are associated with an increased risk of bleeding among patients receiving warfarin. The recent availability of data from the Medicare Part D prescription drug program provides an opportunity to assess the association of antibiotic medications and the risk of bleeding in a national population of older adults receiving warfarin.

Methods: We conducted a case-control study nested within a cohort of 38,762 patients aged 65 years and older who were continuous warfarin users, using enrollment and claims data for a 5% national sample of Medicare beneficiaries with Part D benefits. Cases were defined as patients hospitalized for a primary diagnosis of bleeding and were matched with 3 control subjects on age, race, sex, and indication for warfarin. Logistic regression analysis was used to calculate adjusted odds ratios (aORs) and 95% confidence intervals (CIs) for the risk of bleeding associated with prior exposure to antibiotic medications.

Results: Exposure to any antibiotic agent within the 15 days of the event/index date was associated with an increased risk of bleeding (aOR 2.01; 95% CI, 1.62-2.50). All 6 specific antibiotic drug classes examined (azole antifungals [aOR, 4.57; 95% CI, 1.90-11.03], macrolides [aOR, 1.86; 95% CI, 1.08-3.21], quinolones [aOR, 1.69; 95% CI, 1.09-2.62], cotrimoxazole [aOR, 2.70; 95% CI, 1.46-5.05], penicillins [aOR, 1.92; 95% CI, 1.21-2.07], and cephalosporins [aOR, 2.45; 95% CI, 1.52-3.95]) were associated with an increased risk of bleeding.

Conclusion: Among older continuous warfarin users, exposure to antibiotic agents-particularly azole antifungals-was associated with an increased risk of bleeding.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: There are no conflicts of interest. All authors had access to the data and a role in writing this manuscript.

References

    1. Jacobs LG. Warfarin pharmacology, clinical management, and evaluation of hemorrhagic risk for the elderly. Clin Geriatr Med. 2005;22:17–32. - PubMed
    1. Fischer HD, Juurlink DN, Mamdani M, Kopp A, Laupacis A. Hemorrhage during warfarin therapy associated with cotrimoxazole and other urinary tract anti-infective agents. Arch Intern Med. 2010;170:617–21. - PubMed
    1. Zhang K, Young C, Berger J. Administrative claims analysis of the relationship between warfarin use and risk of hemorrhage including drugdrug and drug-disease interactions. J Manag Care Pharm. 2006;12:640–7. - PMC - PubMed
    1. Juurlink DN. Drug interactions with warfarin: what clinicians need to know. CMAJ. 2007;177:369–71. - PMC - PubMed
    1. Schelleman H, Bilker WB, Brensinger CM, Han X, Kimmel SE, Hennessy S. Warfarin, fluoroquinolones, sulfonamides, or azole antifungals interactions and the risk of hospitalization for gastrointestinal bleeding. Clin Pharmacol Ther. 2008;84:581–8. - PMC - PubMed

Publication types